Francisco Javier Carrillo-Salinas
Francisco Javier Carrillo-Salinas
Verified email at
Cited by
Cited by
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors
M Mecha, A Feliú, PM Iñigo, L Mestre, FJ Carrillo-Salinas, C Guaza
Neurobiology of disease 59, 141-150, 2013
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
M Mecha, A Feliú, FJ Carrillo-Salinas, A Rueda-Zubiaurre, ...
Brain, behavior, and immunity 49, 233-245, 2015
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
M Mecha, AS Torrao, L Mestre, FJ Carrillo-Salinas, R Mechoulam, ...
Cell death & disease 3 (6), e331-e331, 2012
A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis
AG Granja, F Carrillo-Salinas, A Pagani, M Gómez-Cañas, R Negri, ...
Journal of Neuroimmune Pharmacology 7 (4), 1002-1016, 2012
Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus
M Mecha, FJ Carrillo-Salinas, L Mestre, A Feliu, C Guaza
Progress in neurobiology 101, 46-64, 2013
Microglia activation states and cannabinoid system: Therapeutic implications
M Mecha, FJ Carrillo-Salinas, A Feliú, L Mestre, C Guaza
Pharmacology & therapeutics 166, 40-55, 2016
Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
T Nevers, AM Salvador, F Velazquez, N Ngwenyama, FJ Carrillo-Salinas, ...
Journal of Experimental Medicine 214 (11), 3311-3329, 2017
Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
M Hernangómez, F J Carrillo-Salinas, M Mecha, F Correa, L Mestre, ...
Current pharmaceutical design 20 (29), 4707-4722, 2014
Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure
I Valiente-Alandi, SJ Potter, AM Salvador, AE Schafer, T Schips, ...
Circulation 138 (12), 1236-1252, 2018
A Sativex®‐like combination of phytocannabinoids as a disease‐modifying therapy in a viral model of multiple sclerosis
A Feliú, M Moreno‐Martet, M Mecha, FJ Carrillo‐Salinas, E De Lago, ...
British journal of pharmacology 172 (14), 3579-3595, 2015
Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
F Laso-García, J Ramos-Cejudo, FJ Carrillo-Salinas, L Otero-Ortega, ...
PLoS One 13 (9), e0202590, 2018
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
FJ Carrillo-Salinas, C Navarrete, M Mecha, A Feliú, JA Collado, ...
PloS one 9 (4), e94733, 2014
2-Arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination
A Feliú, IB del Río, FJ Carrillo-Salinas, G Hernández-Torres, L Mestre, ...
Journal of Neuroscience 37 (35), 8385-8398, 2017
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at …
M Mecha, A Feliú, FJ Carrillo-Salinas, L Mestre, C Guaza
Experimental neurology 250, 348-352, 2013
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
C Navarrete, F Carrillo-Salinas, B Palomares, M Mecha, ...
Journal of neuroinflammation 15 (1), 1-19, 2018
Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
FJ Carrillo-Salinas, L Mestre, M Mecha, A Feliú, R Del Campo, ...
Scientific Reports 7, 44377, 2017
Chromenopyrazole, a versatile cannabinoid scaffold with in vivo activity in a model of multiple sclerosis
P Morales, M Gómez-Cañas, G Navarro, DP Hurst, FJ Carrillo-Salinas, ...
Journal of medicinal chemistry 59 (14), 6753-6771, 2016
2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
M Mecha, A Feliú, I Machín, C Cordero, F Carrillo‐Salinas, L Mestre, ...
Glia 66 (7), 1447-1463, 2018
PDE 7 inhibitor TC 3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis
L Mestre, M Redondo, FJ Carrillo‐Salinas, JA Morales‐García, ...
British journal of pharmacology 172 (17), 4277-4290, 2015
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9 …
M Moreno-Martet, A Feliú, F Espejo-Porras, M Mecha, FJ Carrillo-Salinas, ...
Multiple sclerosis and related disorders 4 (6), 505-511, 2015
The system can't perform the operation now. Try again later.
Articles 1–20